CRISPR (CRSP) Rated Overweight on Gene Editing Growth

31 3 月, 2026

One Min Read

5 Views

原文: https://finance.yahoo.com/markets/stocks/articles/crispr-crsp-rated-overweight-gene-084606764.html

Last Update: 31 3 月, 2026

Written By

Other Articles

Previous

Rocket Lab (RKLB) Rated Buy on $190M Defense Contract

Next

Canaccord Maintains Hold on Joby (JOBY) Amid Flight Testing Milestones

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept